Restoring Brain and Body Performance in the
Toughest Conditions—
Supporting astronauts, special forces, and clinicians with AI, biosensing, and neurogames — validated in space, translated to Earth.
Space Validates. Earth Benefits.
Microgravity acts as a natural simulator of cognitive disease—giving MyelinSpace a head start in detecting, treating, and preventing functional decline before it becomes irreversible.
RECOGNISED BY NASA
Top 10 Inventions | NASA iTech Programme
"From orbital stress to battlefield burnout—our neurotech was validated in space to heal on Earth."
Collaborating with Pioneers in Space
Technology Overview
A Neurotechnology Platform for Recovery, Readiness, & Research—on Earth and in Space
MyelinSpace is an AI-powered platform designed to monitor, enhance, and accelerate brain-body recovery in high-stakes and high-stress conditions.
From space missions and defence settings to clinical trials for neurodegenerative diseases, our technology bridges the gap between operational performance and long-term health.
Key Application Areas
1. Space-Inspired Pharma & Clinical Research
Challenge: Brain diseases like multiple sclerosis, Parkinson's, and Alzheimer's require new biomarkers and faster drug trials.
Solution: MyelinSpace turns space environments (microgravity, isolation, sensory stress) into simulators of brain ageing and neurodegeneration.
This allows us to:
- Model disease progression under stress
- Track early functional improvements before structural brain changes
- Accelerate go/no-go drug decisions
- Support pharma trials with adaptive neurocognitive endpoints
2. Translational Impact: Space to Earth
What works for astronauts also helps patients.
Solution: We apply insights from space neurobiology to improve rehabilitation for:
This allows us to:
- MS & neuroinflammatory conditions
- Cognitive decline in ageing
- Dementia
- Parkinson's Disease
- Post-concussion syndromes
3. Cognitive Performance & Recovery
Challenge: Fatigue, overload, and impaired decision-making under stress.
Solution: MyelinSpace monitors attention, stress, and executive function in real-time, delivering AI-driven recalibration protocols for sustainable recovery and peak readiness.
4. Neurorecovery & Stress Resilience
Challenge: Burnout, trauma, and performance decline in extreme conditions.
Solution: We support post-mission recovery, psychological decompression, and neurofeedback rehabilitation for special forces, pilots, and astronauts.
What MyelinSpace Enables
🧪 Drug Discovery & Response Profiling in Space
Accelerate drug discovery by simulating disease-like brain changes in space and modelling functional response under microgravity.
🧠 NeuroRecovery After Critical Missions
Support mental, cognitive, and physical recovery after spaceflight, or high-risk operations using real-time AI monitoring.
🎮 Cognitive Training & Mental Readiness
Use immersive neurogames and AI-guided routines to boost attention, memory, and stress resilience before deployment.
🚀 Enhanced Readiness in Extreme Environments
Track and optimise cognitive and physical performance for astronauts, pilots, and deep-space missions.
Why MyelinSpace?
Feature
Value
Ready to Transform Your Organization's Cognitive Performance?
Join the pioneers in space medicine and extreme performance optimization. Connect with our team to explore how MyelinSpace can revolutionize your approach to cognitive and physical recovery.
Space-Validated Technology
NASA iTech Top 10 recognized platform tested in the most extreme conditions
Real-Time AI Monitoring
Advanced neurocognitive tracking that detects changes in minutes, not months
Dual-Use Applications
Perfect for both clinical research and defense/space health initiatives
Speak with our team about your specific requirements
Or learn more about our key applications and technology overview
Disclaimer: MyelinZ products, including BodyMirror, are intended for personal brain and body wellness and research use only. They are not classified as medical devices under EU Directive 93/42/EEC and are not intended for the diagnosis, treatment, or prevention of any disease. For regulated clinical use, MyelinZ is developing dedicated medical-grade technologies under the R‑MMS programme.
©2025 MyelinZ, All rights reserved.